baber/WOPTO huggingface dataset:
Patent JP-3784423-B2 (JP)
IPC: H04L9/10
Filed: 1993-05-14
Granted: 2006-06-14
Abstract: Method and apparatus are disclosed including a system monitor which limits the ability of a program about to be executed to the use of predefined resources (e.g., data files, disk writing capabilities, etc.). The system monitor processes a data structure including a set of authorities defining that which a program is permitted to do and/or that which the program is precluded from doing. The set of authorities and/or restrictions assigned to a program to be executed are referred to as "program authorization information" (or "PAI"). Once defined, the program authorization information is thereafter associated with at least one program to be executed to thereby delineate the resources and functions that the program is allowed to utilize and/or is not allowed to utilize. The PAI associated with a particular program may be assigned by a computer system owner/user or by someone who the computer system owner/user implicitly trusts. The PAI permits an associated program to access what has been authorized and nothing else. The program may be regarded as being placed in a program capability limiting "safety box". This "safety box" is thereafter associated with the program such that when the system monitor runs the program, the PAI for that program is likewise loaded and monitored. When the program is to perform a function or access a resource, the associated PAI is monitored to confirm that the operation is within the defined program limits. If the program is prevented from doing anything outside the authorized limits. <IMAGE>
Patent JP-H0723323-B2 (JP)
IPC: A61P19/10
Filed: 1986-05-30
Abstract: gamma -IFN is used to prepare a pharmaceutical having a regulatory action on the processes occurring in the formation and destruction of bone.
Patent JP-S6010080-B2 (JP)
IPC: C11D1/75
Filed: 1977-11-04
Abstract: An improved cleaning composition, comprising an amine oxide, an alkylether sulphate, casein and optionally other nonionic detergent compounds and an organophosphorus compound. The composition, which is free from alkylbenzene sulphonates, alkyl sulphonates and alkyl sulphates, has improved drain-dry properties and improved mildness properties.
Patent JP-3866370-B2 (JP)
IPC: C08G18/28
Filed: 1997-05-13
Granted: 2007-01-10
Abstract: Alkoxysilane- and hydantoin groups exhibiting polyurethane prepolymers of formula (I) are new, where A = group formed by removal of the NCO- groups from an isocyanate prepolymer with an NCO-content of 0.4-5% and an average functionality of 1.5-4; R = 1-8C alkyl group; and X, Y, Z = 1-4C alkyl- or alkoxy group, provided that at least one of the groups is an alkoxy group. In (I), A = a group which is formed by removal of the NCO-groups from an isocyanate prepolymer based on polyether polyols with an average functionality of 1.8-2.2 and an NCO-content of 0.5-2%; R = 1-2C alkyl group; and X, Y, Z = methoxy- or ethoxy groups.
Patent JP-H0336707-B2 (JP)
IPC: F16D65/28
Filed: 1983-07-30
Abstract: PURPOSE:To prevent the occurrence of interference lying between a spring chamber part and other constituent parts, by setting up the spring chamber part and a push rod of the chamber part in parallel and on a straight line along an axle in relation to a wheel cylinder part. CONSTITUTION:A wheel cylinder 21 is solidly formed with a wedge cylinder 22 in almost parallel with an axle. A third piston 34 is slidably inserted into a hollow chamber 22c of the wedge cylinder 22. A first push rod 14 pivoted on a setting shaft 12 of a first piston 6 in a spring chamber part 2 is made to come into contact with the piston 34. And, those of wedge cylinder 22, push rod 14 and spring chamber part 2 are all set up on a straight line.
Patent JP-S637459-B2 (JP)
IPC: H01L21/52
Filed: 1980-10-23
Abstract: PURPOSE:To avoid a short circuit phenomena caused by a conductive piece by a method wherein the part of the chip-sticking surface of a ceramic package on which a semiconductor chip is not placed is coated with thermal resistant resin after the semiconductor chip is placed. CONSTITUTION:After a chip 2 is bonded to a surface 7 for sticking a chip of a ceramic package 1, the remaining surface is coated with polyimide or thermal resistant silicon resin 8. Through the situation, even if there are small pieces that are easy to be separated on the bottom surface, since they are enclosed in the resin, short circuits of wiring can not be found afterward.
Patent JP-3310017-B2 (JP)
IPC: C04B41/81
Filed: 1992-06-16
Granted: 2002-07-29
Abstract: A solid filler is incorporated within a porous substrate by making use of the steps which consist in: 
 
  - preparing a slip containing the solid filler in the form of finely divided particles dispersed in a liquid carrier, 
  - placing the substrate (20) in an enclosure, 
  - placing the enclosure (22) under vacuum, 
  - allowing the slip to enter the enclosure, and 
  - passing the slip through the substrate using pressure difference while forcing the slip to pass through the substrate a number of times in one direction and in the other. The concentration of solid filler in the slip is determined as a function of the volume percentage of filler desired in the substrate. 
 
<IMAGE>
Patent JP-H0448651-B2 (JP)
IPC: B60K23/00
Filed: 1982-09-17
Abstract: A gear shift position sensing arrangement for a gear selector unit that selects the transmission gears indirectly. Magnetic sensors are arranged in the gear selector unit housing so as to be activated when a permanent magnet associated with the gear shift lever is brought into magnetic proximity therewith.
Patent JP-H0440786-B2 (JP)
IPC: G03C5/00
Filed: 1981-10-14
Abstract: Optcally readable information disc having a radiation cured lacquer layer comprising an optically readable information track whereby the lacquer layer has a minimum identation hardness which corresponds to a maximum depth of penetration of 5  mu m of a needle which is placed on the lacquer layer and which has a ball-shaped tip manufactured from a hard material and having a diameter of 18 +/- 1  mu m and presses on the layer with a weight of 2.5 +/- 0.1 g.
Patent JP-H0829047-B2 (JP)
IPC: A23L29/20
Filed: 1988-07-07
Abstract: The present invention is concerned with an edible plastic dispersion not having a continuous fat phase, including at least two condensed phases, at least one of which is continuous, which dispersion comprises   (I) gel-forming composition (A) containing gelling agent (a) in an amount of 1-8 times the critical concentration, and (II) gel-forming composition (B) containing gelling agent (b) in an amount of 1-8 times the critical concentration, such that   (i) at least one of the gelling agents is an aggregate-forming gelling agent, (ii) at least one of the gelling agents is a gelling agent other than starch, (iii) both gelling agents are gelling agents other than non-waxy intact starch, and   (iv) gelling agent (a) is different from gelling agent (b).     The dispersion according to the present invention does not exhibit deficiences such as brittleness or too much elasticity.
Patent JP-2749539-B2 (JP)
IPC: B44C5/04
Filed: 1995-07-19
Granted: 1998-05-13
Abstract: A multicoloured patterned rubber floor covering has rubber particles of at least one contrasting colour pressed and vulcanised into it. The particles contain at least two constituents whose colours are different from each other and are also different from the base colour. The constituents penetrate each other in a wedge or strip shape and the part showing on the surface of the floor covering must be at least 50% of the same colour. The total visible surface (n) with particles of two colours (1,2) must satisfy the relation ~En1 / ~En2 or with more than two colours (1.......x) ~EN1 / ~En2 / ~Enx.
Patent JP-H0655154-B2 (JP)
IPC: C12R1/19
Filed: 1985-08-22
Abstract: This invention concerns a method for recovering a purified eucaryotic growth hormone or an analog thereof from a bacterial cell in which the growth hormone or analog has been produced by means of expression of a DNA sequence encoding the hormone or analog. The method involves the following steps: (a) disrupting the cell wall of the bacterial cell or fragments thereof to produce a lysate; (b) separating a precipitate containing particulate and insoluble material from the lysate; (c) preparing suspension of the separated precipitate in an appropriate buffer solution; (d) treating the suspension to effect contact between liquid and solids; (e) separating partially or completely precipitated material from the liquid-solids contacted suspension; (f) solubilizing the separated precipitate in a sufficient amount of water and adjusting the pH to a suitable alkaline pH to form a solution; (g) separating the solubilized hormone or analog from other cellular components by ultrafiltration under suitable conditions to produce an ultrafiltrate containing the hormone or analog and a retentate, and (h) treating the solubilized hormone or analog so as to concentrate the hormone or analog and thereby recover purified hormone or analog. Separations may be effected by ultrafiltration or centrifugation. Sonication as well as the ultrafiltration in step (i) may be repeated. Additionally, most of the process steps may be performed in a continuous flow and may be automated. Suitable hormone-producing bacterial cells for use in this invention include genetically modified strains of Escherichia coli. Growth hormones which can be recovered and purified using this invention include bovine, porcine, chicken, and human growth hormones, and analogs thereof.
Patent JP-H0153102-B2 (JP)
IPC: B01L3/02
Filed: 1982-10-28
Abstract: The pipette according to the invention has a body of the pipette at the lower end of which is fitted an end fitting of a calibrated capillary tube in which a piston is movable, and a gripping device at the upper end of the piston. It is characterized in that the piston has, in the region of its upper end intended to be gripped by the gripping device, a flange adapted to cooperate at its upper face with the free ends of the resilient fingers of the gripping device and by its lower face with an abutment surface arranged on the interior surface of the said end fitting of the capillary tube.
Patent JP-3020260-B2 (JP)
IPC: A61K31/557
Filed: 1990-07-27
Granted: 2000-03-15
Abstract: The invention relates to the use of a compound for the manufacture of a medicament for the treatment of ocular hypertension, said compound being of the formula (I): <CHEM> wherein the hydroxyl groups are in either the  alpha  or  beta configuration; the dashed bonds at C-5, C-13 and C-17 represent either a single bond or a double bond which can be in the cis or trans configuration; A or -OH, or a pharmaceutically acceptable salt thereof or -OR1 where R1 is alkyl of 1 to 6 carbon atoms; R is an acyclic hydrocarbon, saturated or unsaturated, having from 1 to 20 carbon atoms, or R is -(CH2)nR2 where n is 0-10 and R2 is an aliphatic ring or an aromatic or heteroaromatic ring.
Patent JP-4327917-B2 (JP)
IPC: B23Q1/60
Filed: 1998-07-16
Granted: 2009-09-09
Abstract: The shrouding movement system has at least four successive sections (10,20,30,40) which move in relation to each other in the withdrawal (B) and insertion (A) directions. A coupling system is positioned relative to a centre section (20) of the group, and a deflection axis (24,26) is at right angles to the withdrawal direction. The path of a recirculating coupling (28) has two coupling zones (28a,28b) flanking the deflection axis with carriers (12) each to work with one of the outer sections (10,30) of the group. The recirculating coupling moves at least partially around the deflection axis between the coupling zones.
Patent JP-H0633417-B2 (JP)
Inventor: HUGE-JENSEN IDA BIRGITTE
IPC: C12N9/20
Filed: 1987-08-29
Abstract: Lipase is derived from Humicola sp. (incl. Thermomyces sp.), preferably H. lanuginosa. This lipase is found to have high activity at alkaline pH and to be compatible with anionic surfactants, and it is more effective as a detergent additive than prevously described detergent lipases.
Patent JP-3930922-B2 (JP)
IPC: C07C211/28
Filed: 1996-08-14
Granted: 2007-06-13
Abstract: Dehalogenation of halo-arylalkylamines comprises treating enantiomers of formula (I) with hydrogenation agent in the presence of a transition metal-contg. hydrogenation catalyst to form enantiomers of formula (II) with retention of the active centre. the asterisk indicates the asymmetric centre, m = 1-3; n = 0-4; R1 and R2 = H, 1-10C alkyl, aryl or together complete a 3-8 membered ring; R3, R4 = H, 1-10C alkyl, aryl or together with N complete a 3-8 membered ring, or with R1 or R2 complete a 3-8 membered ring; X = Cl, I or Br.
Patent JP-2878994-B2 (JP)
IPC: F16H59/38
Filed: 1995-08-31
Granted: 1999-04-05
Abstract: A control system for an automatic transmission, comprising: a fluid transmission unit (12) connected to an engine (10); a clutch (C1); a hydraulic servo (C-1); output RPM detecting means (47) for detecting the output RPM of the fluid transmission unit (12); oil pressure generating means for generating the oil pressure to be fed to the hydraulic servo; and a control unit (40). This control unit includes: booster means (105) for raising the oil pressure according to preset characteristics; change rate detecting means (103) for detecting the RPM change rate of the output RPM in a preset section at the applied of the clutch; and correction means (104) for correcting the characteristics by comparing the detected RPM change rate and a reference RPM change rate. The change rate detecting means (103) detects the RPM change rate only when the output RPM at the time of starting the engagement of the clutch (C1) is higher by a preset value than the maximum of the output RPM in the preset section. <IMAGE>
Patent JP-H0424394-B2 (JP)
IPC: C08G18/00
Filed: 1982-12-22
Abstract: A method of preparing a storage-stable one-part reactive liquid thermal curing polymeric coating composition from an isocyanate-functional polymeric compound which has a substantial portion of its isocyanate groups masked with an isocvanate masking agent, and a crosslinking agent which is substantially insoluble in aprotic solvents. These liquid compositions are homogeneous even when free of solvents. Preferably the crosslinking agent is a crystalline polyol. The method involves the synthesis of a solubilizing oligomer which is formed by the partial reaction of the crosslinking agent and the unmasked isocyanate-functional polymeric compound. The thermal curing of these compositions results in polymeric coatings which possess superior physical properties. These cured coatings are particularly useful in the manufacture of retroreflective sheeting.
Patent JP-3623975-B2 (JP)
IPC: A61P25/04
Filed: 1993-10-01
Granted: 2005-02-23
Abstract: Phthalazinone derivatives (e.g. azelastine, flezelastine) and their optical isomers are used as drugs to control emesis and cardiac arrhythmias, to control pain and to break down multidrug resistance.
Patent JP-H0746876-B2 (JP)
IPC: H04N7/00
Filed: 1985-11-14
Abstract: A method of and apparatus for transferring and processing a plurality of digital data signals which comprise component video signals, comprising the steps of; spatially dividing each of the digital data signals corresponding to the displayed picture into N sections thereof, wherein N is an integer larger than 2; expanding the divided digital data signals by N times in the period of clock frequency of the digital data signals; and distributing the divided and expanded digital data signals into M channels of transmission lines in such a manner that the plurality of the divided and expanded digital data signals are interleaved to each other in each of the M channels of transmission lines, wherein M is an integer larger than 2.
Patent JP-4106135-B2 (JP)
IPC: H01B3/30
Filed: 1998-09-01
Granted: 2008-06-25
Abstract: Stable, blocked polyisocyanate cross-linking agents (I), which do not crystallise in solution, are reaction products based on aliphatic and cycloaliphatic polyisocyanate components and a secondary aliphatic linear amine. (I) are reaction products of: (A) a mixture of 100 equivalent-(eq.)% lacquer polyisocyanates containing allophanate, biuret, isocyanurate, imino-oxadiazindione, uretedione and/or urethane groups, comprising (A1) 30-70 eq.% polyisocyanate component containing 12-24 wt.% isocyanate (NCO) and based on linear, optionally branched aliphatic diisocyanates, and (A2) 30-70 eq.% polyisocyanate component containing 8-15 wt.% NCO and based on cycloaliphatic diisocyanates; (B) 85-100 eq.% (with respect to NCO groups) secondary aliphatic linear amine with boiling point of 60-110 degrees C; optionally (C) 0-15 eq.% (with respect to NCO groups) hydrazine derivative of formula: HO-R-OC(O)-(NH)2-C(O)O-R-OH (II); (Where: R = saturated 2-5 carbon(C) hydrocarbyl); and also optionally contains (D) 0-5.0 wt.% admixed 2,2,6,6-tetramethyl-piperidin-4-yl compound of formula: (III). An Independent claim is also included for the preparation of (I).
Patent JP-2793157-B2 (JP)
IPC: C08G77/02
Filed: 1995-10-13
Granted: 1998-09-03
Abstract: Organopolysiloxane resin solns. are claimed, contg. 10-14C l-alkenes and no aromatic hydrocarbons. Also claimed is: (i) a process for the prodn. of these resin solns.; (ii) crosslinking organopolysiloxane compsns. contg. these resin solns.; and (iii) release additives contg. these resin solns..
Patent JP-H0580499-B2 (JP)
Inventor: FUROIDO HAMIRUTON FUITSUSHU JU
IPC: C08J5/04
Filed: 1985-12-13
Abstract: A composite comprising a matrix resin reinforced with a sliver of high modulus p-aramid fibers of which at least 10% of the fiber ends are fibrillated into at least 2 fibrils along a terminal length which is at least 5 times as long as the diameter of the unfibrillated portion of the fiber.
Patent JP-3434839-B2 (JP)
IPC: C07D501/00
Filed: 1992-09-09
Granted: 2003-08-11
Abstract: The present invention provides an aqueous acylation process for the preparation of antibiotic, cefepime dihydrochloride hydrate which is substantially free of the anti-isomer and the  DELTA <2> isomer comprising the N-acylation of 7-amino-3-[(1-methyl-1-pyrrolidinio)-methyl]ceph-3-em-4-carboxylate with the syn-isomer of 2-(2-aminothiazol-4-yl)-2-methoxyimino acetyl chloride hydrochloride.
Patent JP-H0577399-B2 (JP)
Inventor: YOAHIMU JIIDERU
IPC: C12Q1/28
Filed: 1985-12-20
Abstract: 1. Process for the improvement of the colorimetric determination of H2 O2 , which is formed by an H2 O2 -producing oxidase, by addition of a chromogenic system and measurement of the coloured material formed characterized in that, as H2 O2 -producing oxidase, one uses a non-O-2  radical-forming oxidase and adds superoxide dismutase, E.C.1.15.1.1, to the reagent solution.
Patent JP-4350235-B2 (JP)
IPC: C12N15/54
Filed: 1999-10-12
Granted: 2009-10-21
Abstract: Recombinant kinase remaining stable during the synthesis of nucleoside monophosphate without the addition of stabilizing SH reagents, without stabilizing proteins and accepting all four natural deoxynucleotides, obtainable from insect cells such as e.g. Drosophila Melanogaster. In addition, the invention concerns DNA sequences, vectors, transformed cells, a method for production of the recombinant kinase as well as its use for preparing nucleoside monophosphates. <IMAGE>
Patent JP-3008488-B2 (JP)
IPC: F01N3/32
Filed: 1990-11-22
Granted: 2000-02-14
Abstract: A secondary air supply system of a vehicle, including an engine unit (7) having a crank chamber (8) and being operatively connected to an air cleaner (11) and an exhaust system including an exhaust pipe (14), comprises a diaphragm pump device (1) provided with an inner chamber (4a,4b,4c) and having an air inlet port (9) and an air outlet port (12) both being communicated with the inner chamber, a diaphragm (2) disposed in the inner chamber to divide it into a diaphragm chamber (3) and a pump chamber (4a,4b,4c), a first hose (10) connecting the air inlet port (9) and the air cleaner (11) to introduce a secondary air from the air cleaner (11) into the pump chamber (4a), a second hose (13) connecting the air outlet port (12) and the exhaust pipe (14) to supply the secondary air into the exhaust pipe (14) through the outlet port (12), and a third hose (6) connecting the diaphragm chamber (3) of the diaphragm pump device (1) and the crank chamber (8) of the engine unit (7). The secondary air is supplied into the exhaust pipe (14) through the diaphragm pump (1) by an amount in proportion to a magnitude of an oscillation of the diaphragm (2) caused in accordance with a pressure variation in the crank chamber (8) caused in proportion to an engine revolution speed. A valve assembly (5a,5b) is further disposed in the pump chamber (4a,4b,4c) for allowing the secondary air introduced into the pump chamber (4a,4b,4c) to flow uni-directionaly from the inlet port (9) to the outlet port (12). <IMAGE>   <IMAGE>
Patent JP-3345382-B2 (JP)
IPC: C08K5/00
Filed: 1999-12-02
Granted: 2002-11-18
Abstract: Silicone rubber composition contains a platinum complex having at least one unsaturated group, a metal oxide and boric acid or zinc borate. A composition (I) contains a peroxide or condensation cross-linked silicone rubber, a metal oxide consisting of magnesium oxide, aluminum oxide, tin oxide, calcium oxide, barium oxide or precursor compounds that form oxides on heating, boric acid or zinc borate and platinum complexes having at least one unsaturated group. Independent claim are included for: (i) a process for the preparation of (I) by mixing the components; (ii) cable or a profile that contains (I).
Patent JP-3239319-B2 (JP)
IPC: A61K9/16
Filed: 1991-12-03
Granted: 2001-12-17
Abstract: A method for the manufacture of oral controlled release dosage units containing hydroxypropyl methylcellulose wherein the aqueous granulation is performed in the presence of one or more solutes, which inhibit gel formation during the granulation but allows the formation of a gel when administered orally. Also the new dosage units prepared according to the invention are included.
Patent JP-4170385-B2 (JP)
IPC: A61L15/26
Filed: 1992-06-22
Granted: 2008-10-22
Abstract: The method of adjusting the saturation concentration of a drug in a transdermal composition for application to the dermis, which comprises mixing polymers having differing solubility parameters, so as to modulate the delivery of the drug. This results in the ability to achieve a predetermined permeation rate of the drug into and through the dermis. In one embodiment, a dermal composition of the present invention comprises a drug, an acrylate polymer, and a polysiloxane. The dermal compositions can be produced by a variety of methods known in the preparation of drug-containing adhesive preparations, including the mixing of the polymers, drug, and additional ingredients in solution, followed by removal of the processing solvents. The method and composition of this invention permit selectable loading of the drug into the dermal formulation and adjustment of the delivery rate of the drug from the composition through the dermis, while maintaining acceptable shear, tack, and peel adhesive properties.
Patent JP-H0771465-B2 (JP)
IPC: A23P30/32
Filed: 1988-02-15
Abstract: Fragmentation by explosion of organic products, simplifying the subsequent processing of the blasted particles of same, particularly of seed, fruits and vegetables, said device being provided with at least one pressure chamber (1), a pressure release chamber (3) disposed below said pressure chamber, and an isolating element (4) between said pressure chamber (1) and said pressure release chamber (3). The pressure release chamber (3) extends horizontally, whilst a separating device (10) in the pressure release chamber (3) is disposed in such a way that the hard particles, such as fruit stones, stalks and the remains of shells, which have not been blasted by inhomogenous blasting, may be separated from the other, blasted particles and transported separately from the pressure release chamber (3).